David L. Concannon
Partner
dconcannon@andrewskurth.com

450 Lexington Avenue
New York NY 10017
P: 212.850.2855
F: 210.850.2929

Download v-card

David's practice includes significant experience in general corporate and securities work with an emphasis on capital markets, merger and acquisition and venture capital transactions for technology companies; specifically formation and organization of start-ups, venture capital financings, public offerings of debt and equity securities, public and private mergers and acquisitions, restructurings, joint ventures and other corporate partnering arrangements, and counseling regarding, among others, general corporate matters, financings, mergers and acquisitions and securities law compliance for public and private corporations.

Representative Experience

Representative venture capital transactions include:

• Counsel to Monitor110, Inc. in connection with $11 million Series C Preferred Stock financing
• Counsel to United BioFuels Europe Cayman Holdings Ltd. in connection with €10 million Series C Preferred Stock financing
• Counsel to Monitor110, Inc. in connection with $5 million Series B Preferred Stock financing
• Counsel to United BioFuels Europe Cayman Holdings Ltd. in connection with $25 million Series B Preferred Stock financing
• Counsel to UR Power GmbH in connection with €12.5 million Series C Preferred Stock financing
• Counsel to George Soros in connection with $14 million Series A Preferred Stock financing of LabNow, Inc.
• Counsel to Perseus-Soros BioPharmaceutical Fund, L.P. in connection with $48 million Series C Preferred Stock financing of Avera Pharmaceuticals, Inc.
• Counsel to Perseus-Soros BioPharmaceutical Fund, L.P. in connection with $8 million Series B Preferred Stock financing of ArgiNOx Pharmaceuticals, Inc.
• Counsel to Currenex, Inc. in connection with $3.75 million Series B-1 Preferred Stock financing
• Counsel to Perseus-Soros BioPharmaceutical Fund, L.P. in connection with $37 million Series A Preferred Stock financing of CardioKine, Inc.
• Counsel to TL Ventures and affiliates in connection with $15 million Series B Preferred Stock financing of Circadiant Systems, Inc.

Representative capital markets transactions include:

• Counsel to Hydrogenics Corporation in connection with $84 million initial public offering of common shares
• Counsel to Merrill Lynch, Pierce, Fenner & Smith Incorporated as underwriter in connection with $90 million initial public offering of common stock of Adolor Corporation
• Counsel to Merrill Lynch, Pierce, Fenner & Smith Incorporated as underwriter in connection with $240 million initial public offering of class A common shares of Iridium World Communications Ltd.
• Counsel to RightChoice Managed Care, Inc. in connection with $35 million initial public offering of common stock
• Counsel to Vanguard Airlines, Inc. in connection with initial public offering of common stock
• Counsel to American Safety Razor Company in connection with $60 million initial public offering of common stock

Representative merger and acquisition transactions include:

• Counsel to Dynova Laboratories, Inc. in connection with cash and stock acquisition of SiCap Industries, LLC
• Counsel to Atlas Holdings LLC in connection with cash acquisition (merger) of Pangborn Holdings Inc.
• Counsel to Currenex, Inc. in connection with its $564 million cash sale to State Street Corporation
• Counsel to Agricapital GmbH in connection with spinoff of its vegetable-oil fueled power plant division
• Counsel to Agricapital GmbH in connection with spinoff of its Hungarian ethanol-biogas power plant division
• U.S. Counsel to Apax Partners in connection with £173 million asset purchase of Regent Biogel and Hibi businesses from SSL International plc.
• Counsel to PSINet Consulting Solutions Holdings, Inc. in connection with its sale of the assets of its Enterprise Solutions Division
• Counsel to BevAccess.com, Inc. in connection with acquisition of The Beverage Media Group, Ltd.
• Counsel to Axsys Technologies, Inc. in connection with divestiture of Beau Interconnect division
• Counsel to Forstmann Little & Co. in connection with $2.4 billion cash sale (stock) of Ziff-Davis Holdings Corp. to Softbank Corporation
• Counsel to Columbia/HCA Healthcare Corporation in connection with the $1.4 billion cash acquisition (tender offer) of Value Health, Inc.
• Counsel to Forstmann Little & Co. in connection with $1.4 billion cash acquisition (tender offer) of Community Health Systems, Inc.
• Counsel to Guardian Royal Exchange Assurance Ltd. in connection with $1.2 billion cash acquisition of ING US P&C Corporation
• Counsel to AEA Investors Inc. in connection with $70.0 million stock purchase of Manchester Tank & Equipment Co.

Professional / Civic Affiliations

Member

• New York State Bar Association
• New York New Media Association
• American Bar Association

Listed - New York Super Lawyers 2007 in Securities & Corporate Finance, Metro Magazine (September 2007)

Headline News

• Clean and Renewable Energy Practice Earns No. 2 U.S. Ranking (June 13, 2007)

Industries

• Venture Capital and Emerging Companies
• Technology
• Software/Electrical
• Internet/E-Commerce
• Private Equity

Practice Areas

• Corporate/Securities
• Technology and Emerging Companies
• Private Equity

Education

• JD, 1990, Vanderbilt University School of LawAB, 1987, University of Michigan

Admitted

• Missouri 1994
  New York 1992